Study of blood coagulation in women treated with megestrol acetate implants

Keyphrases

• Blood Coagulation 100%
• Blood Coagulation Disorders 33%
• Blood Coagulation Tests 33%
• Clotting Time 33%
• Continuous Treatment 33%
• Contraceptives 33%
• Euglobulin Clot Lysis Time 33%
• Fibrinogen 33%
• Follicular Phase 33%
• Generation Time 33%
• Long-term Administration 33%
• Megestrol Acetate 100%
• No Significant Difference 33%
• Partial Thromboplastin Time 33%
• Platelet Adhesiveness 33%
• Platelet Count 33%
• Prothrombin 33%
• Prothrombin Time 33%
• Subdermal Implant 33%
• Thromboplastin 33%

Biochemistry, Genetics and Molecular Biology

• Coagulation System 100%
• Coagulopathy 33%
• Fibrinogen 33%
• Follicular Phase 33%
• Megestrol Acetate 100%
• Normal Value 33%
• Partial Thromboplastin Time 33%
• Platelet Count 33%
• Prothrombin 33%
• Prothrombin Time 33%
• Thrombocyte Adhesion 33%
• Thromboplastin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Blood Clotting Disorder 33%
• Clotting Time 33%
• Contraceptive Agent 33%
• Fibrinogen 33%
• Implant 100%
• Megestrol Acetate 100%
• Prothrombin 100%
• Thromboplastin 66%